Janney Montgomery Scott cut shares of Endo Health Solutions (NASDAQ:ENDP) from a neutral rating to a sell rating in a research report sent to investors on Wednesday morning, TheFlyOnTheWall.com reports. The firm currently has $28.50 price target on the stock, down from their previous price target of $34.00.
Shares of Endo Health Solutions (NASDAQ:ENDP) traded down 0.03% during mid-day trading on Wednesday, hitting $36.81. Endo Health Solutions has a one year low of $25.01 and a one year high of $40.19. The stock’s 50-day moving average is currently $38.11. The company’s market cap is $4.132 billion.
ENDP has been the subject of a number of other recent research reports. Analysts at Morgan Stanley initiated coverage on shares of Endo Health Solutions in a research note to investors on Wednesday, July 24th. They set an equal weight rating on the stock. Separately, analysts at Oppenheimer initiated coverage on shares of Endo Health Solutions in a research note to investors on Friday, June 21st. They set a market perform rating on the stock. Finally, analysts at RBC Capital raised their price target on shares of Endo Health Solutions from $27.00 to $29.00 in a research note to investors on Thursday, June 6th.
Six research analysts have rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating to the company’s stock. The stock currently has an average rating of Hold and an average price target of $35.77.
Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.